Invest Now
Samco securities limited
Samco Star Rating Ads

Strides Pharma Science Ltd

₹ 1,559.45 +44.00 (2.90%)

Updated on 12-10-2024 6:56 AM

Stock Rating

Pros 1

 

Cons 8

Price Performance

  • Day's Low
  • ₹1,525
  • Day's High
  • ₹1,586.05
₹ 1,559.45
  • 52-w low
  • ₹467
  • 52-w high
  • ₹1,586.05
1,559.45
  • Day's open
    ₹1,525
  • Previous close
    ₹1,515.45
  • VWAP
    ₹1,563.75
  • Lower price band
    ₹1,247.60
  • Upper price band
    ₹1,871.30

Today's Market Action

The last traded share price of Strides Pharma Science Ltd was 1,559.45 up by 2.90% on the NSE. Its last traded stock price on BSE was 1,561.45 up by 2.97%. The total volume of shares on NSE and BSE combined was 549,668 shares. Its total combined turnover was Rs 85.96 crores.

Medium and Long Term Market Action

Strides Pharma Science Ltd hit a 52-week high of 1,586.05 on 12-10-2024 and a 52-week low of 467 on 06-11-2023. The stock price of Strides Pharma Science Ltd is up by 16% over the last one month. It is up by 208.74% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 14340

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Strides Pharma Science Ltd?

What is the Market Cap of Strides Pharma Science Ltd?

What is PE Ratio of Strides Pharma Science Ltd?

What is PB Ratio of Strides Pharma Science Ltd?

What is the CAGR of Strides Pharma Science Ltd?

How to Buy Strides Pharma Science Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 1.81 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.95. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 209 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 65% of the total company's shareholding which can have a significantly negative impact on stock.
  • Negative Margin of Safety
    The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(13/10/2024)
Stock Valuation
Red line
73
100.00%
100.00% People are bullish about Strides Pharma Science Ltd
0.00%
0.00 % People are bearish about Strides Pharma Science Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Strides Pharma Science Ltd

₹ 1,559.45 +44.00 (2.90%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon